An EC proposal to ban the repackaging of medicines to help stamp out drug counterfeiting has attracted widespread opposition. The Medicines and Healthcare products Regulatory Agency, the Guild of Healthcare Pharmacists and the Pharmaceutical Group of the European Union all share concerns about the proposal, which is part of a wider consultation package. The MHRA, on behalf of the Government, says the ban would prevent importers from elsewhere in the EU meeting UK regulations requiring that all medicines should have labels and patient leaflets in English in both primary and secondary containers. It also believes that sealing the outer packaging of products would have little effect in combating counterfeiting because seals can easily be copied.
展开▼
